ImmunityBio (IBRX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

IBRX is expected to report earnings to rise 30.56% to -23 cents per share on August 09

Q2'23

Est.

$-0.23

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.17

Q3'23

Est.

$-0.19

Q1'23

Est.

$-0.27

The last earnings report on May 07 showed earnings per share of -18 cents, beating the estimate of -19 cents. With 3.18M shares outstanding, the current market capitalization sits at 2.74B.

View a ticker or compare two or three

Compare

IBRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IBRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for IBRX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a producer of cancer treatment products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3530 John Hopkins Court

Phone

+1 844 696-5235

Employees

628

Web

https://www.immunitybio.com